[How to minimize the secondary effects of antiretrovirals].
Ramón
R
Cernadas
D019380:Anti-HIV Agents / Q000009:adverse effects*; D001847:Bone Diseases / Q000139:chemically induced / Q000517:prevention & control; D005221:Fatigue / Q000139:chemically induced / Q000517:prevention & control; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000517:prevention & control
D019380:Anti-HIV Agents